唯代若靜脈輸注液
Land: Taiwan
Taal: Chinees
Bron: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Bijsluiter
(PIL)
15-06-2021
Openbaar beoordelingsrapport
(PAR)
15-06-2021
Verzend verzoek.
Werkstoffen:
POLY(O-2 HYDROXYETHYL )STARCH;;SODIUM CHLORIDE;;CALCIUM CHLORIDE DIHYDRATE;;MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O);;SODIUM ACETATE TRIHYDRATE (EQ TO SODIUM ACETATE 3H2O );;POTASSIUM CHLORIDE
Beschikbaar vanaf:
和聯生技藥業股份有限公司 台北市敦化北路３１１號５樓 (04270075)
ATC-code:
B05AA07
farmaceutische vorm:
注射劑
Samenstelling:
SODIUM ACETATE TRIHYDRATE (EQ TO SODIUM ACETATE 3H2O ) (4008000670) MG; CALCIUM CHLORIDE DIHYDRATE (4012000350) MG; MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O) (4012001550) MG; POTASSIUM CHLORIDE (4012001800) MG; SODIUM CHLORIDE (4012002100) MG; POLY(O-2 HYDROXYETHYL )STARCH (9600030283) (molar substitution 0.42, MW130,000)MG
Eenheden in pakket:
塑膠軟袋裝
klasse:
製 劑
Prescription-type:
限由醫師使用
Geproduceerd door:
SERUMWERK BERNBURG AG HALLESCHE LANDSTRABE 105B, 06406 BERNBURG, GERMANY DE
Therapeutisch gebied:
hydroxyethylstarch
therapeutische indicaties:
預防及治療血容積低下及休克
Product samenvatting:
註銷日期: 2016/06/01; 註銷理由: 許可證已逾有效期; 有效日期: 2016/01/13; 英文品名: Vitafusal Solution for Infusion
Autorisatie-status:
已註銷
Autorisatie datum:
2011-01-13
